In cases of unresectable or metastatic disease, cytoreductive surgery (debulking) or liver-directed locoregional therapies—such as embolization, radioembolization, or ablation—may reduce tumor burden and glucagon secretion. The gene discussed is GCG; the disease is neoplasm.